Skip to NavigationSkip to content

Merck KGaA promotes from within new MEA head

Published on: 05/10/17

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, by promoting Paolo Carli from within the company. Carli had previously held the position of Managing Director of the Middle East and Egypt region.

Carli had been working in the previous role for 4 and a half years, after having originally joined Merck as a Director of Corporate Finance, a position he worked in for close to five years focusing upon M&A, and was located in Darmstadt, Germany. Prior to this, he had worked at Deutsche Bank as Vice President of Global Business Development.

Commenting on his appointment Paolo Carli said “Merck prepares to celebrate its 350th year in the pharmaceutical business in 2018. Being a strategic region for Merck, we are committed to excel innovation and create value for patients across this region. I am delighted to lead the MEA team. Our innovative treatment options and sustainable commitment for patients will move us to the next level.”

Carli’s new role will see him responsible for leading commercial operations across MEA.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches